Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/12/2026 | $94.00 | Mkt Perform → Outperform | Bernstein | |
| 2/12/2026 | $189.00 | Outperform → Sector Perform | RBC Capital Mkts | |
| 2/2/2026 | $174.00 | Equal-Weight → Underweight | Morgan Stanley | |
| 1/7/2026 | $290.00 | Overweight → Equal Weight | Wells Fargo | |
| 12/5/2025 | $313.00 | Hold → Buy | Jefferies | |
| 10/14/2025 | $235.00 | Sell | Goldman | |
| 10/14/2025 | $91.00 | Buy | Goldman | |
| 9/22/2025 | $295.00 | In-line | Evercore ISI |
8-K - HUMANA INC (0000049071) (Filer)
S-8 - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
4 - agilon health, inc. (0001831097) (Issuer)
4 - agilon health, inc. (0001831097) (Issuer)
4 - agilon health, inc. (0001831097) (Issuer)
The CenterWell Fulfillment Index offers a new way to understand what drives wellbeing as people age CenterWell, the health care services business of Humana Inc. (NYSE:HUM), today introduced the CenterWell Fulfillment Index, a new national measure to better understand what drives wellbeing as people age. The research reinforces that aging well is more than physical health alone, and that factors like purpose, emotional stability, connection, comfort, independence and security play an important role in how older adults experience their lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420973797/en/ The CenterWell Fulfillm
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Le
Humana Healthcare Research and University of Chicago Medicine study highlights promise of improving respiratory care through remote learning. A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage beneficiaries with COPD use their inhalers more effectively. Researchers from Humana Healthcare Research and University of Chicago Medicine (UChicago Medicine) found that Humana members with COPD and low medication adherence who participated in the program in 2020 significantly improved their inhaler technique after receiving guidance over the phone from pharmaci
4 - agilon health, inc. (0001831097) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - agilon health, inc. (0001831097) (Issuer)
Bernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00
RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00
Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00
George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co
WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (
Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Le
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the first quarter 2026 after market close on Wednesday, May 6, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and +1 (585) 542-9983 for international participants and referencing participant code 206810108. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the call will be availabl
WOONSOCKET, R.I., April 6, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, May 6th, 2026, at 8:00 a.m. ET to discuss first quarter 2026 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2025, the
SC 13G - CVS HEALTH Corp (0000064803) (Subject)
SC 13G/A - agilon health, inc. (0001831097) (Subject)
SC 13G/A - agilon health, inc. (0001831097) (Subject)